唐诗中的瘟疫

通过对唐诗之“疫”的探讨,认为唐朝对疫病产生原因的认识是来源于秦汉以前的疫鬼思想;在治疗方法上采用医师、灸师、诅师、符师四者相结合的医疗手段;并分析了唐代疫病的传播途径、疫区气候条件及唐代疫病的主要类型。     

危重冠心病患者介入治疗的法学思考——从法律学的角度探讨介入治疗的临床适应症

冠心病是目前严重威胁我国人民健康的一种常见病,由于种种原因一部分晚期冠心病患者,来诊时已经失去介入手术和外科搭桥的最佳时机,而且对于这部分病人来讲,药物治疗往往无效,他们的治疗应何去何从,是目前医学界极具争议的话题。试从法律学的角度,探讨危重冠心病患者介入治疗的可能性及必要性,为临床工作提供法律指导。     

人际关系紧张的伦理因素与疾病相关性研究--心身疾病和神经症患者的社会伦理病因调查

伦理道德与健康疾病的相关性研究对预防疾病,增进健康,推动医学模式转变,促进和谐社会的建设有积极的意义.502个病例调查说明,伦理道德与疾病有密切相关性;不道德的因素是危害心身健康的主要伦理因素.     

Selective attention in early Dementia of Alzheimer Type

This study explored possible deficits in selective attention brought about by Dementia of Alzheimer Type (DAT). In three experiments, we tested patients with early DAT, healthy elderly, and young adults under low memory demands to assess perceptual filtering, conflict resolution, and set switching abilities. We found no evidence of impaired perceptual filtering nor evidence of impaired conflict resolution in early DAT. In contrast, early DAT patients did exhibit a global cost in set switching consistent with an inability to maintain the goals of the task (mental set). We discuss these findings in relation to the DAT literature on executive attention, dual-tasking, and working memory.     

药物经济学在疾病管理中的应用

随着近年来慢性病患者的增多,慢性病防治成本的增加,各国政府急需一种方法来降低慢性病患者医疗保健费用,减少卫生资源的浪费;而疾病管理作为解决上述问题的一种有效模式,本文讲述了其定义以及其实施的动因。同时指出药物经济学作为疾病管理中有效的评价工具及其在改善卫生保健资源利用方面的重大作用,阐述了其定义和评价方法,及其在疾病管理中应用时的选取,然后描述了其应用过程中存在的问题及解决对策。     

门诊性病患者的心理问题、产生原因及对应处置决策研究

研究门诊性病患者因承受巨大心理压力而引起的心理健康问题,剖析产生的原因,制定科学的对应处置决策,因人而异地使用药物种类,给予相应的心理治疗,创造良好的就医环境,使患者病痛解除,心理压力释放,身心恢复健康。     

石家庄市区缺血性心脑血管病级预防中阿司匹林的应用状况初探

调查在河北省石家庄市区冠心病和缺血性脑血管病二级预防中阿司匹林的应用状况。通过对原住院患者随访,对内科门诊、专家门诊和社区门诊患者通过问卷调查,收集服用阿司匹林的有关资料,根据阿司匹林的应用情况,将患者分为两组：1组为服药组：患者规范或不规范服用阿司匹林;2组为未用药组：患者从未服阿司匹林。共1885例,其中缺血性脑血管病925例、冠心病711例、冠心病与缺血性脑血管病并存249例。患者来自住院随访患者567例、内科门诊882例、社区门诊436例。全组1885例患者中,服用阿司匹林组为1226例（占比例为65．1％）,其中,规范服用阿司匹林957例（50．8％）,不规范用药269例（14．3％）,未服用阿司匹林659例（34．9％）。阿司匹林在本调查地区缺血性心脑血管病二级预防中的应用率较高,用药的依从性较好,但和阿司匹林规范化应用的专家共识还有较大的差距。     

Consenting to uncertainty: challenges for informed consent to disease screening—a case study

This paper uses chronic beryllium disease as a case study to explore some of the challenges for decision-making and some of the problems for obtaining meaningful informed consent when the interpretation of screening results is complicated by their probabilistic nature and is clouded by empirical uncertainty. Although avoidance of further beryllium exposure might seem prudent for any individual whose test results suggest heightened disease risk, we will argue that such a clinical precautionary approach is likely to be a mistake. Instead, advice on the interpretation of screening results must focus not on risk per se, but on avoidable risk, and must be carefully tailored to the individual. These points are of importance for individual decision-making, for informed consent, and for occupational health.

Diagnosis of Fabry Disease via Analysis of Family History

Fabry disease is an X-linked lysosomal storage condition caused by a deficiency of α-galactosidase A. In order to determine the average number of family members who are diagnosed with Fabry disease following the diagnosis of a proband, four lysosomal storage disease centers across the United States reviewed the completed pedigrees of their Fabry disease patients. In addition, data from three Fabry disease families from other centers were submitted by patients directly. The pedigree review found 74 probands (54 males and 20 females) who had 357 diagnosed family members, of which 223 were female (60.5%) and 146 were male (39.5%). Analysis found that, on average, there were five family members diagnosed with Fabry disease for every proband. Now that enzyme replacement therapy (ERT) is available for the treatment of Fabry disease, this finding emphasizes the need for all health care professionals to ensure a detailed pedigree has been constructed for each patient affected by Fabry disease and to encourage testing and evaluation of all at-risk family members.